318160 — Cell Bio Human Tech Co Cashflow Statement
0.000.00%
- KR₩54bn
- KR₩44bn
- KR₩28bn
- 96
- 65
- 79
- 94
Annual cashflow statement for Cell Bio Human Tech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 4,215 | 3,113 | 2,890 | -1,857 | 4,379 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 1,443 | 3,705 | 1,532 | 2,410 | -715 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3,087 | -743 | -5,842 | -596 | 3,700 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 3,723 | 7,614 | 441 | 1,760 | 9,271 |
Capital Expenditures | -13,249 | -3,850 | -375 | -1,133 | -2,026 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 13,294 | -686 | 4,394 | 3,762 | -2,617 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 45.1 | -4,535 | 4,020 | 2,630 | -4,643 |
Financing Cash Flow Items | — | — | -13,996 | -6,000 | -5 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -8,320 | 4,317 | -13,895 | -4,832 | -5,623 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -4,619 | 7,676 | -9,434 | -442 | -953 |